---
title: "Insights into Baxter Intl Q4 Earnings"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275756363.md"
description: "Baxter Intl (NYSE:BAX) reported Q4 earnings on February 12, 2026, missing estimates by 32.08% with an EPS of $0.36 against an expected $0.53. Revenue increased by $221 million compared to the previous year. In the last quarter, the company had beaten EPS estimates by $0.09, leading to a 3.6% drop in share price the following day. Historical performance shows fluctuations in EPS and revenue across previous quarters."
datetime: "2026-02-12T12:18:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275756363.md)
  - [en](https://longbridge.com/en/news/275756363.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275756363.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275756363.md) | [繁體中文](https://longbridge.com/zh-HK/news/275756363.md)


# Insights into Baxter Intl Q4 Earnings

The Q4 earnings report for **Baxter Intl** (NYSE:BAX) was released on Thursday, February 12, 2026 at 07:15 AM.

Here's what investors need to know about the latest announcement.

### Earnings

Baxter Intl missed estimated earnings by -32.08%, reporting an EPS of $0.36 versus an estimate of $0.53.

Revenue was up $221.00 million from the same period last year.

### Previous Earnings Records

The company beat on EPS by $0.09 in the last quarter, resulting in a 3.6% drop share price change the following day.

Here's a look at Baxter Intl's past performance:

**Quarter**

**Q3 2025**

**Q2 2025**

**Q1 2025**

**Q4 2024**

**EPS Estimate**

0.60

0.61

0.48

0.52

**EPS Actual**

0.69

0.59

0.62

0.77

**Revenue Estimate**

2.87B

2.82B

2.59B

2.67B

**Revenue Actual**

2.83B

2.81B

2.62B

2.75B

To track all earnings releases for Baxter Intl visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [Vanguard Health Care ETF (VHT.US)](https://longbridge.com/en/quote/VHT.US.md)
- [iShares Global Healthcare ETF (IXJ.US)](https://longbridge.com/en/quote/IXJ.US.md)
- [Baxter International Inc. (BAX.US)](https://longbridge.com/en/quote/BAX.US.md)
- [iShares US Medical Devices ETF (IHI.US)](https://longbridge.com/en/quote/IHI.US.md)
- [SPDR® S&P Health Care Equipment ETF (XHE.US)](https://longbridge.com/en/quote/XHE.US.md)
- [State Street®HlthCrSelSectSPDR®ETF (XLV.US)](https://longbridge.com/en/quote/XLV.US.md)

## Related News & Research

- [Geoffrey Beran Rose Sells 7,732 Shares of Pulmonx (NASDAQ:LUNG) Stock](https://longbridge.com/en/news/277978473.md)
- [Pulmonx Q4 revenue beats expectations](https://longbridge.com/en/news/277833961.md)
- [Enovis Corporation $ENOV Shares Sold by Royce & Associates LP](https://longbridge.com/en/news/277474498.md)
- [J&J announces Tecvayli-Darzalex combo approval from FDA for multiple myeloma](https://longbridge.com/en/news/278091420.md)
- [/C O R R E C T I O N -- Johnson & Johnson/ | JNJ Stock News](https://longbridge.com/en/news/277699503.md)